Baseline PSA testing for men in their 40s: Currently available evidence strongly supports baseline PSA measurements in this age group

The benefit-to-risk trade-offs associated with PSA screening are highly sensitive to patient preference, underscoring the importance of ensuring that men have the opportunity to decide for themselves whether they wish to have their individual risk for suffering and death from prostate cancer assessed through PSA screening.